Clinical Trial Update: Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing ranibizumab monotherapy with ranibizumab in combination therapies for recurrent or persistent choroidal neovascularization seco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Age-Related Macular Degeneration, Neovascularization, Choroidal | Phase 2 | Status: COMPLETED